Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice
- PMID: 20546831
- DOI: 10.1016/j.vaccine.2010.05.022
Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice
Abstract
Burkholderia pseudomallei is resistant to a wide range of antibiotics, leading to relapse and recrudescence of melioidosis after cessation of antibiotic therapy. More effective immunotherapies are needed for better management of melioidosis. We evaluated the prophylactic potential of the immunogenic outer membrane protein Omp85 as a vaccine against murine melioidosis. Immunization of BALB/c mice with recombinant Omp85 (rOmp85) triggered a Th2-type immune response. Up to 70% of the immunized animals were protected against infectious challenge of B. pseudomallei with reduced bacterial load in extrapulmonary organs. Mouse anti-rOmp85 promoted complement-mediated killing and opsonophagocytosis of B. pseudomallei by human polymorphonuclear cells. In conclusion, we demonstrated that B. pseudomallei Omp85 is potentially able to induce protective immunity against melioidosis.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.Vaccine. 2009 Jul 16;27(33):4447-51. doi: 10.1016/j.vaccine.2009.05.040. Epub 2009 May 31. Vaccine. 2009. PMID: 19490962
-
Heterologously type IV pilus expressed protein of Burkholderia pseudomallei is immunogenic but fails to induce protective immunity in mice.Southeast Asian J Trop Med Public Health. 2011 Sep;42(5):1190-6. Southeast Asian J Trop Med Public Health. 2011. PMID: 22299445
-
Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle.Trans R Soc Trop Med Hyg. 2008 Dec;102 Suppl 1:S89-94. doi: 10.1016/S0035-9203(08)70022-1. Trans R Soc Trop Med Hyg. 2008. PMID: 19121696
-
Progress toward development of vaccines against melioidosis: A review.Clin Ther. 2010 Aug;32(8):1437-45. doi: 10.1016/j.clinthera.2010.07.020. Clin Ther. 2010. PMID: 20728758 Review.
-
Melioidosis vaccines.Expert Rev Vaccines. 2002 Dec;1(4):477-82. doi: 10.1586/14760584.1.4.477. Expert Rev Vaccines. 2002. PMID: 12901586 Review.
Cited by
-
Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.Front Microbiol. 2014 Jul 29;5:381. doi: 10.3389/fmicb.2014.00381. eCollection 2014. Front Microbiol. 2014. PMID: 25120536 Free PMC article.
-
A Homology Model Reveals Novel Structural Features and an Immunodominant Surface Loop/Opsonic Target in the Treponema pallidum BamA Ortholog TP_0326.J Bacteriol. 2015 Jun;197(11):1906-20. doi: 10.1128/JB.00086-15. Epub 2015 Mar 30. J Bacteriol. 2015. PMID: 25825429 Free PMC article.
-
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies.Sci Rep. 2018 May 8;8(1):7136. doi: 10.1038/s41598-018-25609-z. Sci Rep. 2018. PMID: 29740124 Free PMC article.
-
Evaluation of Highly Conserved Burkholderia pseudomallei Outer Membrane Proteins as Protective Antigens Against Respiratory Melioidosis.Res Sq [Preprint]. 2025 May 13:rs.3.rs-6549424. doi: 10.21203/rs.3.rs-6549424/v1. Res Sq. 2025. Update in: NPJ Vaccines. 2025 Aug 6;10(1):186. doi: 10.1038/s41541-025-01246-2. PMID: 40470231 Free PMC article. Updated. Preprint.
-
Glanders: An ancient and emergent disease with no vaccine or treatment on site.PLoS Negl Trop Dis. 2025 Jun 11;19(6):e0013160. doi: 10.1371/journal.pntd.0013160. eCollection 2025 Jun. PLoS Negl Trop Dis. 2025. PMID: 40498787 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources